Literature DB >> 30919779

The Pattern of Non-AIDS-defining Cancers in the HIV Population: Epidemiology, Risk Factors and Prognosis. A Review.

Marco Franzetti1, Elena Ricci2, Paolo Bonfanti1.   

Abstract

The advent of highly active antiretroviral therapy (HAART) has significantly reduced the incidence of AIDS events, including AIDS-defining malignancies. Nevertheless, several cohort studies conducted in the post-HAART period have reported an increasing risk of non-AIDS-defining cancers (NADC). Overall, the potential mechanisms leading to an increased risk of developing NADCs probably involve multiple known and unknown factors. In addition to ageing, chronic inflammation and ongoing immune system dysregulation, other contributing factors are co-infection with potentially oncogenic viruses (HBV, HCV, HPV, EBV) and high-risk behaviours such as tobacco smoking. As a consequence of these risk factors, high standardized incidence ratios have been consistently reported, mainly in cohort studies regarding smoking-related cancers (lung cancer, but also pharyngeal and kidney cancer), due to the far more common cigarette smoking habit in the HIV-population. Also in the setting of infection-related malignancies, the high frequency of liver cancer, as a consequence of HBV and HCV co-infection is well known. Similarly, HPV infection accounts for the higher risk of anal cancer. On the same line, Hodgkin lymphoma is more frequent in the HIV population, due to the dysregulation and proliferation of EBV-infected lymphocytes. Several studies addressed the direct relationship between immunosuppression and cancer progression, showing that subjects with HIV infection experience higher cancer-specific mortality, as compared to the general population, independently of cancer stage or cancer treatment. In the HIV population, for many NADCs, the prognosis is still worse as compared to the general population. However, an improvement has been reported over the last decades, mainly thanks to more available and adequate treatment chances. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  AIDS; HAART; HIV; NADCs; cancer incidence; cancer mortality.

Mesh:

Year:  2019        PMID: 30919779     DOI: 10.2174/1570162X17666190327153038

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  11 in total

1.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

Review 2.  HIV and Aging in Mainland China: Implications for Control and Prevention Research.

Authors:  Na He; Yingying Ding; Jing Li; Shiying Yuan; Lulu Xu; Shijie Qiao; Xiaohui Xu; Bowen Zhu; Ruizi Shi; John P Barile; Frank Y Wong
Journal:  Curr HIV/AIDS Rep       Date:  2019-12       Impact factor: 5.071

3.  Comprehensive RNA-seq reveals molecular changes in kidney malignancy among people living with HIV.

Authors:  Juan Bao; Jianqing Ye; Jingjing Xu; Shanshan Liu; Lin Wang; Zehuan Li; Qiuyue Li; Feng Liu; Xiaomeng He; Heng Zou; Yanling Feng; Christopher Corpe; Xiaoyan Zhang; Jianqing Xu; Tongyu Zhu; Jin Wang
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-14       Impact factor: 10.183

Review 4.  Contribution of Behavioral Health Factors to Non-AIDS-Related Comorbidities: an Updated Review.

Authors:  Natalie E Chichetto; Brittanny M Polanka; Kaku A So-Armah; Minhee Sung; Jesse C Stewart; John R Koethe; E Jennifer Edelman; Hilary A Tindle; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.495

Review 5.  Immunotherapy in People With HIV and Cancer.

Authors:  Camille E Puronen; Emily S Ford; Thomas S Uldrick
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

6.  Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21.

Authors:  Francisco J Hernández-Walias; Esther Vázquez; Yolanda Pacheco; José M Rodríguez-Fernández; María J Pérez-Elías; Fernando Dronda; José L Casado; Ana Moreno; José M Hermida; Carmen Quereda; Asunción Hernando; Francisco Tejerina-Picado; Víctor Asensi; María J Galindo; Manuel Leal; Santiago Moreno; Alejandro Vallejo
Journal:  J Clin Med       Date:  2020-03-11       Impact factor: 4.241

Review 7.  The contribution of Latin American research to HPV epidemiology and natural history knowledge.

Authors:  L Sichero; M A Picconi; L L Villa
Journal:  Braz J Med Biol Res       Date:  2020-01-31       Impact factor: 2.590

8.  Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin's lymphoma.

Authors:  Christina K S Muller; Julian Spagnuolo; Annette Audigé; Andrew Chancellor; Doris Russenberger; Alexandra U Scherrer; Matthias Hoffmann; Roger Kouyos; Manuel Battegay; Gennaro De Libero; Roberto F Speck
Journal:  Infect Agent Cancer       Date:  2021-04-17       Impact factor: 2.965

Review 9.  Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.

Authors:  Mariana Nunes; Miguel Henriques Abreu; Carla Bartosch; Sara Ricardo
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 5.923

10.  Pseudomonas aeruginosa Stimulates Inflammation and Enhances Kaposi's Sarcoma Herpesvirus-Induced Cell Proliferation and Cellular Transformation through both Lipopolysaccharide and Flagellin.

Authors:  Ashley Markazi; Paige M Bracci; Michael McGrath; Shou-Jiang Gao
Journal:  mBio       Date:  2020-11-10       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.